Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. [electronic resource]
Producer: 20001201Description: 309-20 p. digitalISSN:- 1083-8791
- Adult
- Animals
- Antilymphocyte Serum
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Transplantation -- adverse effects
- Cell Survival
- Combined Modality Therapy
- Cyclophosphamide -- adverse effects
- Cyclosporine
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Female
- Follow-Up Studies
- Genotype
- Graft Enhancement, Immunologic
- Graft Survival
- Graft vs Host Disease -- etiology
- Graft vs Leukemia Effect
- HLA Antigens -- analysis
- Heart Diseases -- chemically induced
- Hematologic Neoplasms -- drug therapy
- Histocompatibility
- Humans
- Leukocyte Transfusion -- adverse effects
- Male
- Mice
- Middle Aged
- Models, Animal
- Phenotype
- Remission Induction
- Reproducibility of Results
- Salvage Therapy
- Survival Analysis
- T-Lymphocytes -- immunology
- Thymus Gland -- radiation effects
- Transplantation Conditioning -- adverse effects
- Transplantation, Homologous -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.